Cafepharma Today

June 10 2025 - Novo Nordisk starts new CagriSema weightloss drug trial
Novo Nordisk starts new CagriSema weightloss drug trial
Vaccine stocks muted as Wall Street takes 'wait and watch' approach after Kennedy's shake-up
A medical device trade war is brewing between the EU and China
Merck antibody drug for RSV approved by FDA
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Four Ways Katie Couric Stacked The Deck Against Gardasil
Forbes
Thursday, December 5, 2013 - 8:29am
tags:
Gardasil, Merck, HPV, vaccines, Cervarix, GSK
AstraZeneca Eyes Forest Labs as Shares Rise
Motley Fool
Thursday, December 5, 2013 - 8:28am
tags:
Forest Labs, AstraZeneca, M&A
J&J Settles FDA Misbranding Case for $1.25 Million
Bloomberg
Thursday, December 5, 2013 - 8:28am
tags:
FDA, JNJ, misbranding, Advanced Sterilization Products, Sterrad Cyclesure 24
Ditching Big Drugmakers for Biotech Brings Leukemia Boon
Bloomberg
Thursday, December 5, 2013 - 8:26am
tags:
chronic lymphocytic leukemia, Gilead, Pharmacyclics, CLL, Roche
Soligenix: 10 Catalysts To Look For In 2014
Seeking Alpha
Thursday, December 5, 2013 - 8:19am
tags:
Soligenix, SGX203, OrbeShield, RiVax, SGX201, SGX942, VeloThrax, orBec
Will These Drugmakers Profit From Patient Weight Loss?
Motley Fool
Wednesday, December 4, 2013 - 3:47pm
tags:
obesity, Victoza, Novo Nordisk, Contrave, Orexigen, Vivus, Qsymia
3 Biopharmas Hoping for Good News From the FDA
Motley Fool
Wednesday, December 4, 2013 - 3:45pm
tags:
FDA, Auxilium, Xiaflex, Gilead, sofosbuvir, GSK, Theravance, Anoro Ellipta
Immunomedics says lung cancer drug IMMU-132 gets orphan drug incentives from FDA
Yahoo/AP
Wednesday, December 4, 2013 - 3:43pm
tags:
Immunomedics, IMMU-132, orphan drugs, small cell lung cancer
Who Benefits From the OncoMed and Celgene Partnership?
Motley Fool
Wednesday, December 4, 2013 - 12:08pm
tags:
OncoMed, Celgene
Tandem Diabetes Successful IPO Quiet Period Expires Soon
Seeking Alpha
Wednesday, December 4, 2013 - 11:46am
tags:
devices, Tandem Diabetes, IPOs, insulin pumps, diabetes
Boehringer Ingelheim looks for a buyer for its troubled Bedford operation
Fierce Pharma
Wednesday, December 4, 2013 - 11:45am
tags:
drug manufacturing, Boehringer Ingelheim
Denmark's Genmab expands biotech collaboration with Janssen
Reuters
Wednesday, December 4, 2013 - 11:44am
tags:
Genmab, Janssen, Duobody antibodies
Unilife: A Look At The Novartis News
Seeking Alpha
Wednesday, December 4, 2013 - 11:43am
tags:
Unilife, Novartis
Teva Sees $3 Billion in 2020 Sales of Reformulated Drugs
Bloomberg
Wednesday, December 4, 2013 - 11:42am
tags:
Teva
How The Global Pharma Industry Will Shape Up In The Next 5 Years?
Seeking Alpha
Wednesday, December 4, 2013 - 11:38am
tags:
Bristol-Myers Squibb, GSK, JNJ, Ophthotech, Novartis, Regeneron, Roche, Sanofi
FDA Clears ARCA Bio To Start Landmark Personalized Medicine Clinical Trial
Seeking Alpha
Wednesday, December 4, 2013 - 11:10am
tags:
FDA, ARCA biopharma, personalized medicine, Gencaro
Roche teams with Molecular Partners on armed proteins in $1B-plus deal
Fierce Biotech
Wednesday, December 4, 2013 - 10:18am
tags:
Roche, Molecular Partners, DARPin
BioDelivery Sciences: Delivering Profits In 2014
Seeking Alpha
Wednesday, December 4, 2013 - 10:16am
tags:
BioDelivery Sciences, Bunavail, BEMA
St. Jude Medical launches another neurostim trial, hits 52-week high
Mass Device
Wednesday, December 4, 2013 - 9:26am
tags:
Neurostim, St. Jude Medical, devices
2014 Could Be A Big Year For Inovio, Merrimack, And NeoStem
Seeking Alpha
Wednesday, December 4, 2013 - 9:24am
tags:
Inovio, Merrimack Pharmaceuticals, NeoStem, VGX-3100, MM-398, AMR-001

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.